143 related articles for article (PubMed ID: 20420574)
41. Neurotoxicity mechanisms of thioether ecstasy metabolites.
Capela JP; Macedo C; Branco PS; Ferreira LM; Lobo AM; Fernandes E; Remião F; Bastos ML; Dirnagl U; Meisel A; Carvalho F
Neuroscience; 2007 Jun; 146(4):1743-57. PubMed ID: 17467183
[TBL] [Abstract][Full Text] [Related]
42. Inhibition potential of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites on the in vitro monoamine oxidase (MAO)-catalyzed deamination of the neurotransmitters serotonin and dopamine.
Steuer AE; Boxler MI; Stock L; Kraemer T
Toxicol Lett; 2016 Jan; 243():48-55. PubMed ID: 26721607
[TBL] [Abstract][Full Text] [Related]
43. The mixture of "ecstasy" and its metabolites is toxic to human SH-SY5Y differentiated cells at in vivo relevant concentrations.
Barbosa DJ; Capela JP; Silva R; Vilas-Boas V; Ferreira LM; Branco PS; Fernandes E; Bastos Mde L; Carvalho F
Arch Toxicol; 2014 Feb; 88(2):455-73. PubMed ID: 24101030
[TBL] [Abstract][Full Text] [Related]
44. The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.
Gouzoulis-Mayfrank E; Daumann J
J Psychopharmacol; 2006 Mar; 20(2):188-93. PubMed ID: 16510477
[TBL] [Abstract][Full Text] [Related]
45. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
[TBL] [Abstract][Full Text] [Related]
46. Ecstasy induces apoptosis via 5-HT(2A)-receptor stimulation in cortical neurons.
Capela JP; Fernandes E; Remião F; Bastos ML; Meisel A; Carvalho F
Neurotoxicology; 2007 Jul; 28(4):868-75. PubMed ID: 17572501
[TBL] [Abstract][Full Text] [Related]
47. Prefrontal N-acetylaspartate is strongly associated with memory performance in (abstinent) ecstasy users: preliminary report.
Reneman L; Majoie CB; Schmand B; van den Brink W; den Heeten GJ
Biol Psychiatry; 2001 Oct; 50(7):550-4. PubMed ID: 11600108
[TBL] [Abstract][Full Text] [Related]
48. A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on dopamine neurones in mouse brain.
Colado MI; Camarero J; Mechan AO; Sanchez V; Esteban B; Elliott JM; Green AR
Br J Pharmacol; 2001 Dec; 134(8):1711-23. PubMed ID: 11739248
[TBL] [Abstract][Full Text] [Related]
49. Sprague-Dawley rats display metabolism-mediated sex differences in the acute toxicity of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).
Fonsart J; Menet MC; Declèves X; Galons H; Crété D; Debray M; Scherrmann JM; Noble F
Toxicol Appl Pharmacol; 2008 Jul; 230(1):117-25. PubMed ID: 18358511
[TBL] [Abstract][Full Text] [Related]
50. Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): a stressor on the immune system.
Connor TJ
Immunology; 2004 Apr; 111(4):357-67. PubMed ID: 15056370
[TBL] [Abstract][Full Text] [Related]
51. Synergistic toxicity of ethanol and MDMA towards primary cultured rat hepatocytes.
Pontes H; Sousa C; Silva R; Fernandes E; Carmo H; Remião F; Carvalho F; Bastos ML
Toxicology; 2008 Dec; 254(1-2):42-50. PubMed ID: 18848861
[TBL] [Abstract][Full Text] [Related]
52. Ecstasy (3,4-methylenedioxymethamphetamine)-induced inappropriate antidiuretic hormone secretion.
Farah R; Farah R
Pediatr Emerg Care; 2008 Sep; 24(9):615-7. PubMed ID: 18797371
[TBL] [Abstract][Full Text] [Related]
53. Nitroxide antioxidant as a potential strategy to attenuate the oxidative/nitrosative stress induced by hydrogen peroxide plus nitric oxide in cultured neurons.
Lee CT; Yu LE; Wang JY
Nitric Oxide; 2016 Apr; 54():38-50. PubMed ID: 26891889
[TBL] [Abstract][Full Text] [Related]
54. The role of mitochondrial uncoupling in 3,4-methylenedioxymethamphetamine-mediated skeletal muscle hyperthermia and rhabdomyolysis.
Rusyniak DE; Tandy SL; Hekmatyar SK; Mills E; Smith DJ; Bansal N; MacLellan D; Harper ME; Sprague JE
J Pharmacol Exp Ther; 2005 May; 313(2):629-39. PubMed ID: 15644431
[TBL] [Abstract][Full Text] [Related]
55. Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition.
de la Torre R; Farré M; Roset PN; Pizarro N; Abanades S; Segura M; Segura J; Camí J
Ther Drug Monit; 2004 Apr; 26(2):137-44. PubMed ID: 15228154
[TBL] [Abstract][Full Text] [Related]
56. Role of oxidative stress in Deoxynivalenol induced toxicity.
Mishra S; Dwivedi PD; Pandey HP; Das M
Food Chem Toxicol; 2014 Oct; 72():20-9. PubMed ID: 25010452
[TBL] [Abstract][Full Text] [Related]
57. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
58. Ecstasy: are animal data consistent between species and can they translate to humans?
Easton N; Marsden CA
J Psychopharmacol; 2006 Mar; 20(2):194-210. PubMed ID: 16510478
[TBL] [Abstract][Full Text] [Related]
59. Neurotoxic effects of MDMA (ecstasy) on the developing rodent brain.
Dzietko M; Sifringer M; Klaus J; Endesfelder S; Brait D; Hansen HH; Bendix I; Felderhoff-Mueser U
Dev Neurosci; 2010 Aug; 32(3):197-207. PubMed ID: 20616555
[TBL] [Abstract][Full Text] [Related]
60. On the mechanisms underlying 3,4-methylenedioxymethamphetamine toxicity: the dilemma of the chicken and the egg.
Puerta E; Hervias I; Aguirre N
Neuropsychobiology; 2009; 60(3-4):119-29. PubMed ID: 19893329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]